Covered recipient · General Payments record
LORRAINE F SCHIEFFER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,994.18
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $224.18 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ACADIA Pharmaceuticals Inc | $38.00 | 1 |
| SK Life Science, Inc. | $34.09 | 1 |
| JAZZ PHARMACEUTICALS INC. | $33.68 | 1 |
| Neurelis, Inc. | $30.78 | 1 |
| Marinus Pharmaceuticals, Inc. | $29.32 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $20.88 | 1 |
| Metacel Pharmaceuticals LLC | $19.42 | 1 |
| Sumitomo Pharma America, Inc. | $18.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $38.00 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148013208 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $20.88 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144455585 | CMS |
| JAZZ PHARMACEUTICALS INC. | $33.68 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151297016 | CMS |
| Marinus Pharmaceuticals, Inc. | $29.32 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141325196 | CMS |
| Metacel Pharmaceuticals LLC | $19.42 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099648315 | CMS |
| Neurelis, Inc. | $30.78 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145670260 | CMS |
| SK Life Science, Inc. | $34.09 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154130135 | CMS |
| Sumitomo Pharma America, Inc. | $18.01 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148993234 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.